GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Pacific Biosciences of California Inc (FRA:P09) » Definitions » 3-Year Revenue Growth Rate

Pacific Biosciences of California (FRA:P09) 3-Year Revenue Growth Rate : 20.60% (As of Dec. 2023)


View and export this data going back to 2010. Start your Free Trial

What is Pacific Biosciences of California 3-Year Revenue Growth Rate?

Pacific Biosciences of California's Revenue per Share for the three months ended in Dec. 2023 was €0.20.

During the past 12 months, Pacific Biosciences of California's average Revenue per Share Growth Rate was 38.50% per year. During the past 3 years, the average Revenue per Share Growth Rate was 20.60% per year. During the past 5 years, the average Revenue per Share Growth Rate was 5.10% per year. During the past 10 years, the average Revenue per Share Growth Rate was -2.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Pacific Biosciences of California was 38.90% per year. The lowest was -22.00% per year. And the median was 7.10% per year.


Competitive Comparison of Pacific Biosciences of California's 3-Year Revenue Growth Rate

For the Medical Devices subindustry, Pacific Biosciences of California's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pacific Biosciences of California's 3-Year Revenue Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Pacific Biosciences of California's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Pacific Biosciences of California's 3-Year Revenue Growth Rate falls into.



Pacific Biosciences of California 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


Pacific Biosciences of California  (FRA:P09) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.


Pacific Biosciences of California 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Pacific Biosciences of California's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Pacific Biosciences of California (FRA:P09) Business Description

Traded in Other Exchanges
Address
1305 O’Brien Drive, Menlo Park, CA, USA, 94025
Pacific Biosciences of California Inc is a biotechnology company focused on the design, development, and commercialization of tools for biological research. The company develops sequencing systems to assist in resolving genetically complex problems. Its sequencing systems provide access to a wide range of applications and are designed for expandable improvements to performance capability. The majority of the company's revenue is derived from North America, followed by Asia and Europe.

Pacific Biosciences of California (FRA:P09) Headlines

No Headlines